These novel treatments, Tirzepatide , represent a remarkable advancement in addressing metabolic dysfunction and possibly related conditions . These drugs are categorized as GLP-1 hormone agonists , meaning they to replicate the endogenous GLP-1 peptide, enhancing insulin production and lowering food intake. While Semaglutide every operates relativ